Evidence map›Paper›PMID 40969820›Full record

ArticleJuntendo medical journal2025

History of Disseminated Intravascular Coagulation (DIC) Research and My Personal Research History.

Toshiaki Iba

Abstract read
In one paragraph

Article in Juntendo medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Toshiaki Iba

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disseminated intravascular coagulation (DIC) is like a cloud. We really can see it, but we never feel or touch it. This means that we can diagnose it, but we still do not know how that happens and how to manage it. DIC was first recognized as an uncontrollable bleeding disorder complicated by critical diseases. Curiously, despite such bleeding tendency, pathological examination revealed systemic micro-clot formation in multiple organs. Soon after, these specific findings were revealed as the result of excess coagulation followed by consumptive coagulopathy. Numerous factors, such as imbalanced coagulation/fibrinolysis, endothelial damage, platelet activation, and intravascular inflammation, are involved in the pathogenesis. However, the whole story has not been clarified yet, and DIC is also recognized as "Disseminated Intracerebral Confusion." In nearly 40 years, several diagnostic criteria were proposed but never integrated. As for the sepsis-associated DIC, the International Society on Thrombosis and Haemostasis recommended a two-step approach by Sepsis-Induced Coagulopathy (SIC) followed by overt DIC criteria. In this approach, the early (compensated)-phase is diagnosed by SIC, and the late (decompensated)-phase is diagnosed by overt DIC criteria. Regarding treatment, we are very sorry, but only the treatment for underlying conditions is recommended. However, aggressive anticoagulant therapies for early-phase DIC have been explored in Japan. We expect the effects of anticoagulant therapy to be proven in the near future.

Indexed as

coagulationdiagnostic criteriadisseminated intravascular coagulationfibrinolysissepsis

Identifiers

PMID40969820
PMCPMC12441178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.